BC Week In Review | Feb 18, 2013
Company News

Oval Medical deal

Oval said it partnered with an undisclosed pharmaceutical company to evaluate combining Oval's auto-injector technology with an undisclosed drug from the pharma to treat severe infections in patients with chronic lung disease. Oval said initial...
BC Week In Review | May 21, 2012
Company News

Oval Medical deal

An undisclosed pharma and Oval partnered to evaluate combining the pharma's drug with Oval's autoinjector technology. The pharma will have the option to jointly develop and commercialize an autoinjector product with Oval. Details were not...
BC Week In Review | Nov 21, 2011
Company News

Oval Medical, AptarGroup deal

Oval Medical granted AptarGroup a license to IP. AptarGroup's Aptar Pharma unit will have access to Oval Medical's IP in undisclosed therapeutic areas for R&D. Oval Medical, which is developing auto-injector technology for drug delivery,...
BC Week In Review | Nov 21, 2011
Financial News

Oval Medical completes venture financing

Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug delivery   Date completed: 11/16/11   Type: Venture financing   Raised: £2 million ($3.2 million)   Investor: AptarGroup  ...
BC Week In Review | Apr 25, 2011
Company News

Oval Medical deal

Two undisclosed pharmaceutical companies will perform feasibility studies using Oval's auto injector technology. Further terms were not disclosed. Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug delivery  ...
BC Week In Review | Jan 31, 2011
Financial News

Oval Medical completes venture financing

Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug delivery   Date completed: 1/6/11   Type: Venture financing   Raised: £1 million ($1.7 million)   Investors: Cambridge Angels; Cambridge Capital Group; Team Consulting; new investors...
BC Week In Review | Oct 11, 2010
Company News

Oval Medical board of directors update

Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug Delivery   Appointed: Peter Keen as chairman, currently senior independent director at Abcam plc, chairman of Exosect Ltd. and non-executive director of Ark Therapeutics Group plc...
Items per page:
1 - 7 of 7
BC Week In Review | Feb 18, 2013
Company News

Oval Medical deal

Oval said it partnered with an undisclosed pharmaceutical company to evaluate combining Oval's auto-injector technology with an undisclosed drug from the pharma to treat severe infections in patients with chronic lung disease. Oval said initial...
BC Week In Review | May 21, 2012
Company News

Oval Medical deal

An undisclosed pharma and Oval partnered to evaluate combining the pharma's drug with Oval's autoinjector technology. The pharma will have the option to jointly develop and commercialize an autoinjector product with Oval. Details were not...
BC Week In Review | Nov 21, 2011
Company News

Oval Medical, AptarGroup deal

Oval Medical granted AptarGroup a license to IP. AptarGroup's Aptar Pharma unit will have access to Oval Medical's IP in undisclosed therapeutic areas for R&D. Oval Medical, which is developing auto-injector technology for drug delivery,...
BC Week In Review | Nov 21, 2011
Financial News

Oval Medical completes venture financing

Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug delivery   Date completed: 11/16/11   Type: Venture financing   Raised: £2 million ($3.2 million)   Investor: AptarGroup  ...
BC Week In Review | Apr 25, 2011
Company News

Oval Medical deal

Two undisclosed pharmaceutical companies will perform feasibility studies using Oval's auto injector technology. Further terms were not disclosed. Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug delivery  ...
BC Week In Review | Jan 31, 2011
Financial News

Oval Medical completes venture financing

Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug delivery   Date completed: 1/6/11   Type: Venture financing   Raised: £1 million ($1.7 million)   Investors: Cambridge Angels; Cambridge Capital Group; Team Consulting; new investors...
BC Week In Review | Oct 11, 2010
Company News

Oval Medical board of directors update

Oval Medical Technologies Ltd. , Cambridge, U.K.   Business: Drug Delivery   Appointed: Peter Keen as chairman, currently senior independent director at Abcam plc, chairman of Exosect Ltd. and non-executive director of Ark Therapeutics Group plc...
Items per page:
1 - 7 of 7